insilico Insilico Raises $35M From Aramco Venture Arm For AI Drug Discovery Hong Kong-based Insilico secures $35 million in Series D funding led by Aramco's Prosperity7 to advance its AI-driven drug discovery and sustainable chemistry efforts.
ai Charm Therapeutics Raises $50M to Simulate Protein-Drug Interactions With AI Charm Therapeutics secures $50 million in Series A funding to advance its DragonFold platform, which uses artificial intelligence to predict how drug molecules bind to target proteins. This co-folding technology aims to accelerate the discovery of highly selective precision medicines.
theranos Theranos Jury Begins Deliberations in Elizabeth Holmes Fraud Trial A California jury begins weighing three months of testimony to decide if Theranos founder Elizabeth Holmes committed wire fraud. Holmes faces up to 20 years in prison if convicted on all charges.
techcrunch Cellino Wins TechCrunch Disrupt 2021 Startup Battlefield Cellino takes home the top prize at TechCrunch Disrupt 2021 with its automated stem cell production platform, beating out 19 other startups. Nth Cycle, a company turning battery waste into valuable minerals, earns the runner-up position.
techcrunch Five Startups Advance to TechCrunch Disrupt 2021 Battlefield Finals Twenty startups compete for a $100,000 prize, but only five advance to the final pitch stage at TechCrunch Disrupt 2021. The finalists include innovators in blockchain, battery recycling, African fintech, and stem cell manufacturing.
cellino Cellino Leverages AI and Lasers to Automate Stem Cell Production Cellino showcases a new platform at TechCrunch Disrupt that uses artificial intelligence and lasers to automate the manual process of creating stem cell therapies, aiming to drastically increase yields and lower costs.
nvidia Nvidia and Harvard AI Toolkit Slashes Genome Analysis Time and Cost A new AI tool called AtacWorks dramatically accelerates genome analysis by producing high-quality results from tiny cell samples in under 30 minutes. The breakthrough significantly lowers the cost barrier for rare and single-cell experiments.
israel Israeli Investors Predict Record Growth Beyond Cybersecurity Israeli venture capitalists report strong momentum following a record-breaking 2020 for startup funding and IPOs, pointing to emerging sectors like AI, fintech, and biotech as the next major drivers of growth.
pfizer Pfizer Seeks Emergency Approval for Highly Effective COVID-19 Vaccine Pfizer officially asks U.S. regulators for emergency use authorization of its COVID-19 vaccine, which shows 95% effectiveness. Limited vaccine supplies could reach Americans by next month.
moderna Moderna Reports High Effectiveness in Late-Stage COVID-19 Vaccine Trial Moderna reveals that its experimental COVID-19 vaccine demonstrates strong effectiveness at preventing the virus. This breakthrough adds a second highly viable candidate to the global pandemic response.
moderna Moderna Covid-19 Vaccine Shows 94.5% Efficacy in Late-Stage Trials Moderna reports that its two-dose coronavirus vaccine demonstrates a 94.5% effectiveness rate in preventing Covid-19. The promising results follow a similar announcement from Pfizer as regulators prepare for fast-tracked emergency approvals.
coronavirus Rapid Virus Tests, 3D Printed Bugs, and the Universe's Matter Mystery This week's top tech stories highlight a push for universal coronavirus self-testing, a breakthrough in printing cheap insect-like robots, and new clues explaining why the universe contains matter instead of nothing.
opioids U.S. Researchers Test Brain Implants to Treat Severe Opioid Addiction Medical researchers at West Virginia University are conducting the first U.S. clinical trial using deep brain simulation to combat treatment-resistant opioid addiction. The implanted device aims to monitor and curb addiction-related impulses in real time.
y combinator 82 Startups Showcase Innovations on Day Two of YC Summer 2019 Y Combinator wraps up its Summer 2019 Demo Days with 82 additional startups presenting disruptive solutions across biotech, logistics, and SaaS. The two-day event features a total of 166 companies aiming to transform their respective industries.
pathai PathAI Secures $60 Million for AI-Powered Disease Detection Technology PathAI raises $60 million to advance its computer vision technology that analyzes cell samples for diseases. The company currently focuses on pharmaceutical research while preparing for clinical trials within the next two years.